The 2012 American Urological Association (AUA) Basic Sciences Symposium "Nanomedicine: Applications in Urology," was held at the 2012 AUA Annual Meeting in Atlanta, Georgia on Friday, May 18, 2012.
The goals of this conference were to advance progress in urology, recruit and stimulate the interest of individuals engaged in or having an interest in traditional and non-traditional urologic research, and to build bridges among basic scientists, academic urologists active in research and clinical urologists interested in research. The conference focused on an overarching basic science theme of broad appeal to attract a multidisciplinary audience. Juxtaposing the conference to the beginning of the meeting increased the presence of basic science researchers at the Annual Meeting and attracted further interest from the urology community.
Understanding how to harness the power and innovation inherent in the field of nanotechnology has the potential to revolutionize patient care across the spectrum of urologic diseases including development of approaches to drug delivery, improvement of drug bioavailability, and use of nanoparticles in oncology, particularly in imaging and nanonephrology. The program provided an overview of the field to describe the current state of research via keynote talks from leaders in the field, integrates and discusses the application of the topic to urology research, and explores the translational aspects of the topic.
The Program Chairs were Research Director of Johns Hopkins Medical Institutions Robert Getzenberg, PhD, and Director of the National Cancer Institute Office of Cancer Nanotechnology Research Piotr Grodzinski, PhD. The program speakers were Edward Garmey, MD (Cerulean Pharma, Inc.); Alexis Te, MD (Weill Cornell); Richard Lee, MD (Weill Cornell); Martin Pomper, MD (Johns Hopkins); Stephen Curley, MD (MD Anderson); and Dong Shin, MD (Emory).